According to Sarepta Therapeutics
's latest financial reports the company has $0.96 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $0.85 B | 123.23% |
2022-12-31 | $0.38 B | -58.52% |
2021-12-31 | $0.92 B | 21.82% |
2020-12-31 | $0.76 B | -6.9% |
2019-12-31 | $0.81 B | -20.74% |
2018-12-31 | $1.03 B | 30.8% |
2017-12-31 | $0.78 B | 134.4% |
2016-12-31 | $0.33 B | 76.88% |
2015-12-31 | $0.19 B | -23.14% |
2014-12-31 | $0.24 B | 0.19% |
2013-12-31 | $0.24 B | 99.87% |
2012-12-31 | $0.12 B | 298.75% |
2011-12-31 | $31.01 M | -1201.06% |
2010-12-31 | $-2.82 M | -111.92% |
2009-12-31 | $23.63 M | 50.2% |
2008-12-31 | $15.73 M | -40.37% |
2007-12-31 | $26.38 M | -30.04% |
2006-12-31 | $37.71 M | -29.72% |
2005-12-31 | $53.66 M | 104.27% |
2004-12-31 | $26.26 M | -39.46% |
2003-12-31 | $43.39 M | 84.8% |
2002-12-31 | $23.48 M | -23.1% |
2001-12-31 | $30.53 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Gilead Sciences GILD | $22.74 B | 2,266.75% | ๐บ๐ธ USA |
PTC Therapeutics
PTCT | -$0.9 B | -193.00% | ๐บ๐ธ USA |
Novavax NVAX | -$0.72 B | -174.59% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | -$0.22 B | -122.81% | ๐บ๐ธ USA |
Insmed INSM | -$0.34 B | -134.53% | ๐บ๐ธ USA |
BioCryst Pharmaceuticals
BCRX | -$0.46 B | -147.39% | ๐บ๐ธ USA |
Avidity Biosciences RNA | $0.50 B | -47.90% | ๐บ๐ธ USA |